BridgePoint Medical is focused on developing innovative and proprietary technology in the field of interventional cardiology for access to and treatment of chronic total occlusions. Peripheral vascular products licensed to Covidien in 2012. Company acquired by Boston Scientific in 2012.  
  Apnex Medical is focused on pioneering medical innovations to improve the health of people with obstructive sleep apnea. Apnex sold its assets to Cyberonics in 2013.  
  ClarVista is focused on novel solutions in cataract surgery. Company sold to Alcon in 2017.  

Prospex Medical Home | Management | Portfolio | Contact